Vera Therapeutics, Inc.
NASDAQ:VERA
41.99 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 45.681 | 114.653 | 79.674 | 53.654 | 3.195 |
| Short Term Investments
| 115.035 | 71.194 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 160.716 | 114.653 | 79.674 | 53.654 | 3.195 |
| Net Receivables
| 0 | 0 | 0 | 0.052 | 0 |
| Inventory
| 0 | 0 | 0 | 0.472 | 0 |
| Other Current Assets
| 4.827 | 11.045 | 2.863 | 0.083 | 0.004 |
| Total Current Assets
| 165.543 | 125.698 | 82.537 | 54.261 | 3.565 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 3.041 | 5.173 | 0 | 0 | 1.394 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.011 | 0.058 | 0.867 | 0.293 | 0.363 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 6.951 | 0.506 | 0.344 | 0 | 0.059 |
| Total Non-Current Assets
| 10.003 | 5.737 | 1.211 | 0.293 | 1.816 |
| Total Assets
| 175.546 | 131.435 | 83.748 | 54.554 | 5.381 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 11.118 | 11.991 | 1.385 | 0.909 | 0.342 |
| Short Term Debt
| 2.436 | 2.645 | 0 | 0.002 | 0.122 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0.533 | 0.376 |
| Other Current Liabilities
| 8.749 | 10.964 | 6.305 | 0.962 | 0.22 |
| Total Current Liabilities
| 22.303 | 25.6 | 7.69 | 2.406 | 1.06 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 49.877 | 28.641 | 4.923 | 0 | 0.01 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1.681 | 0.286 | 1.543 | 141.496 | 40.859 |
| Total Non-Current Liabilities
| 51.558 | 28.927 | 6.466 | 141.496 | 40.869 |
| Total Liabilities
| 73.861 | 54.527 | 14.156 | 143.902 | 41.929 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 83.748 | 139.576 | 40.095 |
| Common Stock
| 0.044 | 0.028 | 0.021 | 0.004 | 0.004 |
| Retained Earnings
| -309.102 | -213.112 | -124.056 | -91.447 | -38.034 |
| Accumulated Other Comprehensive Income/Loss
| 0.251 | -0.224 | -83.748 | -139.58 | -40.099 |
| Other Total Stockholders Equity
| 410.492 | 290.216 | 193.627 | 2.099 | 1.486 |
| Total Shareholders Equity
| 101.685 | 76.908 | 69.592 | -89.348 | -36.548 |
| Total Equity
| 101.685 | 76.908 | 69.592 | -89.348 | -36.548 |
| Total Liabilities & Shareholders Equity
| 175.546 | 131.435 | 83.748 | 54.554 | 5.381 |